- $83.81bn
- $101.99bn
- £31.38bn
- 70
- 69
- 83
- 88
REG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSK Capital PLC - Notice of Optional Redemption
AnnouncementREG - GlaxoSmithKline PLC - Sanofi/GSK agree up to 72m Canada COVID doses
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Sanofi/GSK: Phase 1/2 trial of COVID-19 vaccine
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - US FDA approves GSK’s BLENREP for multiple myeloma
AnnouncementREG - GlaxoSK Capital PLC - Publication of a Prospectus
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Sanofi/GSK to supply EU with 300m COVID 19 doses
AnnouncementREG - GlaxoSmithKline PLC - Sanofi & GSK picked for Op. Warp Speed by US Gov.
Announcement